Home › Funds › Ally Bridge Group (NY) LLC › AXSM
Ally Bridge Group (NY) LLC position in AXSM
AXSOME THERAPEUTICS INC. · Health Care
Ally Bridge Group (NY) LLC reported holding 16,493 shares of AXSM (AXSOME THERAPEUTICS INC.) in its Q2 2026 13F filing — a position valued at US$4.0M, representing 3.57% of its reported portfolio and ranking #6 among its reported holdings. Ally Bridge Group (NY) LLC has disclosed AXSM holdings in 5 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Ally Bridge Group (NY) LLC's AXSM position evolved
Ally Bridge Group (NY) LLC first disclosed a stake in AXSM in Q3 2023 at 110,600 shares (US$7.7M). The position peaked in Q4 2023 at 100,862 shares, worth US$8.0M. Across 5 filings, Ally Bridge Group (NY) LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 16,493 shares valued at US$4.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 110.60K | $7.73M | New |
| Q4 2023 | 100.86K | $8.03M | Reduce |
| Q4 2024 | 66.66K | $5.64M | New |
| Q1 2025 | 50.00K | $5.83M | Reduce |
| Q2 2026 | 16.49K | $4.04M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AXSM and 13F data
AXSM (AXSOME THERAPEUTICS INC.) is a Health Care company. 54 other funds we track also report a position in AXSM — the largest reported positions include Deep Track Capital, LP (US$171.3M), ALETHEA CAPITAL MANAGEMENT, LLC (US$158.8M), Hood River Capital Management LLC (US$98.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AXSM
- Deep Track Capital, LP 700.00K sh · $171.34M · Q2 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 648.76K sh · $158.80M · Q2 2026
- Hood River Capital Management LLC 402.68K sh · $98.56M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 316.82K sh · $77.53M · Q2 2026
- Integral Health Asset Management, LLC 300.00K sh · $73.43M · Q2 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 254.28K sh · $62.24M · Q2 2026
- SAMLYN CAPITAL, LLC 246.01K sh · $60.22M · Q2 2026
- PFM Health Sciences, LP 219.60K sh · $53.75M · Q2 2026
- Tri Locum Partners LP 219.31K sh · $53.68M · Q2 2026
- First Turn Management, LLC 218.41K sh · $53.46M · Q2 2026
More on Ally Bridge Group (NY) LLC
FAQ
How long has Ally Bridge Group (NY) LLC held AXSM?
Ally Bridge Group (NY) LLC has disclosed AXSM holdings in 5 of the last 12 reported quarters, going back to Q3 2023.
What is Ally Bridge Group (NY) LLC's current position in AXSM?
As of Q2 2026, Ally Bridge Group (NY) LLC holds 16.49K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $4.04M, representing 3.57% of its reported portfolio and ranking #6.
Has Ally Bridge Group (NY) LLC been buying or selling AXSM?
In the latest 13F filing (Q2 2026), Ally Bridge Group (NY) LLC newly opened its position in AXSM. The position peaked in Q4 2023 at 100.86K shares.
Which other funds hold AXSM?
Other major institutional holders of AXSM include Deep Track Capital, LP, ALETHEA CAPITAL MANAGEMENT, LLC, Hood River Capital Management LLC, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.